TY  - JOUR
AU  - Dirschka, T
AU  - Ekanayake-Bohlig, S
AU  - Dominicus, R
AU  - Aschoff, R
AU  - Herrera-Ceballos, E
AU  - Botella-Estrada, R
AU  - Hunfeld, A
AU  - Kremser, M
AU  - Schmitz, B
AU  - Lübbert, H
AU  - Puig, S
PY  - 2018
DO  - 10.1111/jdv.15185
UR  - http://hdl.handle.net/10668/12724
T2  - Journal of the European Academy of Dermatology and Venereology : JEADV
AB  - The most effective treatment modality for actinic keratosis (AK) is photodynamic therapy (PDT). Major obstacles of PDT are the need of a special illumination device and pain accompanying the illumination. These issues may be overcome by replacing an...
LA  - en
KW  - Administration, Cutaneous
KW  - Aged
KW  - Aminolevulinic Acid
KW  - Female
KW  - Gels
KW  - Germany
KW  - Humans
KW  - Keratosis, Actinic
KW  - Male
KW  - Photochemotherapy
KW  - Photosensitizing Agents
KW  - Prognosis
KW  - Severity of Illness Index
KW  - Skin Cream
KW  - Spain
KW  - Statistics, Nonparametric
KW  - Treatment Outcome
TI  - A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
TY  - research article
VL  - 33
ER  -